Vivian B Neis
Overview
Explore the profile of Vivian B Neis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
422
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Neis V, Werle I, Moretti M, Rosa P, Camargo A, de O Dalsenter Y, et al.
Metab Brain Dis
. 2022 Apr;
37(5):1597-1608.
PMID: 35435610
Cholecalciferol deficiency has been associated with stress-related psychiatric disorders, particularly depression. Therefore, the present study investigated the antidepressant-like effect of cholecalciferol in female mice and the possible role of the...
2.
Budni J, Moretti M, Freitas A, Neis V, Ribeiro C, de Oliveira Balen G, et al.
Behav Brain Res
. 2021 Aug;
414:113512.
PMID: 34358572
Folic acid has been reported to exert antidepressant effects, but its ability to abrogate the depressive-like behavior and signaling pathways alterations elicited by an inflammatory model of depression remains to...
3.
Antidepressant-like effect of guanosine involves activation of AMPA receptor and BDNF/TrkB signaling
Rosa P, Bettio L, Neis V, Moretti M, Kaufmann F, Tavares M, et al.
Purinergic Signal
. 2021 Mar;
17(2):285-301.
PMID: 33712981
Guanosine is a purine nucleoside that has been shown to exhibit antidepressant effects, but the mechanisms underlying its effect are not well established. We investigated if the antidepressant-like effect induced...
4.
Neis V, Moretti M, Rosa P, Dalsenter Y, Werle I, Platt N, et al.
Pharmacol Biochem Behav
. 2020 Aug;
198:173020.
PMID: 32861641
AZD6765 (lanicemine) is a non-competitive NMDA receptor antagonist that induces a fast-acting antidepressant effect without presenting psychotomimetic effects. However, the mechanisms underlying its effects remain to be established. In this...
5.
Camargo A, Dalmagro A, Platt N, Rosado A, Neis V, Zeni A, et al.
Pharmacol Biochem Behav
. 2020 Jun;
196:172971.
PMID: 32585162
Several attempts have been made to understand the role of cholecalciferol (vitamin D) in the modulation of neuropsychiatric disorders. Notably, the deficiency of vitamin D is considered a pandemic and...
6.
Rosa P, Bettio L, Neis V, Moretti M, Werle I, Leal R, et al.
Purinergic Signal
. 2019 Nov;
15(4):491-504.
PMID: 31768875
Although guanosine is an endogenous nucleoside that displays antidepressant-like properties in several animal models, the mechanism underlying its antidepressant-like effects is not well characterized. The present study aimed at investigating...
7.
Camargo A, Pazini F, Rosa J, Wolin I, Moretti M, Rosa P, et al.
J Psychiatr Res
. 2019 May;
115:103-112.
PMID: 31128500
The ketamine's potential for the treatment of refractory depression and anxiety has been considered one the most important discoveries in the last years, however, repeated use of ketamine is limited...
8.
Neis V, Bettio L, Moretti M, Rosa P, Olescowicz G, Fraga D, et al.
Pharmacol Biochem Behav
. 2018 Aug;
173:44-50.
PMID: 30125592
Agmatine is a neuromodulator that has been proposed as a therapeutic strategy for the treatment of major depressive disorder (MDD). A previous study reported that agmatine caused a fast-acting effect...
9.
Neis V, Rosa P, Moretti M, Rodrigues A
Curr Pharm Des
. 2018 Jul;
24(20):2283-2302.
PMID: 30019638
Heme oxygenase (HO) family catalyzes the conversion of heme into free iron, carbon monoxide and biliverdin. It possesses two well-characterized isoforms: HO-1 and HO-2. Under brain physiological conditions, the expression...
10.
Moretti M, Ribeiro C, Neis V, Bettio L, Rosa P, Rodrigues A
Naunyn Schmiedebergs Arch Pharmacol
. 2017 Dec;
391(2):169-176.
PMID: 29222646
Considering the involvement of the opioid system in major depressive disorder (MDD), mainly concerning refractory MDD, and the evidence that ascorbic acid may exert a beneficial effect for the treatment...